Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New meditation program aims to ease cancer symptoms in black patients

NCT ID NCT05763797

Symptom relief Sponsor: M.D. Anderson Cancer Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 17, 2026 · Updated 2 times

Summary

This study tests a supportive care program designed specifically for Black patients with advanced cancer. Participants will join weekly online sessions for four weeks, either practicing meditation or learning coping skills. The goal is to see if this culturally adapted program is practical and helps reduce symptoms like pain and fatigue.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
meditation and coping support program
What this could lead to
If successful, this could provide a culturally relevant supportive care option to help Black patients with advanced cancer manage symptoms and improve quality of life.
What could go wrong
This is a small, early-stage feasibility study (170 participants) testing whether the program works as intended. Results may not apply to all patients, and the program may not reduce symptoms significantly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

170 people

The number who actually took part.

Started

Apr 2023

Expected to finish

Mar 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: For Aim 1, in order to be eligible to participate in this study, a patient must meet all of the following criteria: * Self-identifies as Black/African American * Is ≥18 years old * Was diagnosed with a stage III-IV solid tumor * Is able to provide informed consent For Aims 2 and 3, in order to be eligible to participate in this study, a patient must meet all of the following criteria: * Self-identifies as Black/African American * Is ≥18 years old * Was diagnosed with a stage III-IV solid tumor * Is on active treatment (any line) * Has an ECOG performance status of ≤2 * Has access to the internet * Is able to provide informed consent For Aims 2 and 3, if a family-based intervention is selected as the program format, a patient must meet the additional following criterion: • Has a family caregiver (e.g., spouse, adult child) with whom they currently reside Also, if a family-based intervention is selected as the program format, a caregiver must meet all of the following criteria: * Is ≥18 years old * Has access to the internet * Is able to provide informed consent Exclusion Criteria: For Aim 1, there are no exclusion criteria. For Aims 2 and 3, a patient who meets any of the following criteria will be excluded from participation in this study: * Is pregnant * Has cognitive deficits that would impede the completion of self-report instruments as deemed by the clinical team * Participated in in the Aim 1 of this study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer

Contacts and locations

Locations

  • M D Anderson Cancer Center

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.